Riskpilot← Back to searchSign inGet full accessPreclinapps Oy
OYActiveY-tunnus 2652874-3Raisionkaari 55Research and experimental development on natural sciences and engineering · NACE 7210Est. 20141 employees
Revenue 2025
EUR 61K
+123% vs 2024
EBITDA margin
25.9%
+1238% vs 2024
Equity ratio
44.8%
Financial strength
Net profit 2025
EUR 13K
+1755% vs 2024
| Revenue | EUR 61K | +123% |
| EBITDA | EUR 16K | +1238% |
| Net profit | EUR 13K | +1755% |
| Total assets | EUR 61K | +23% |
| Equity | EUR 27K | +86% |
| Employees | 1 | — |
Legal name
Preclinapps Oy
Y-tunnus number
2652874-3
Legal form
Osakeyhtiö
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
6. marraskuuta 2014
Share capital
EUR 3 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimiala on lääke-, bioteknologia-, diagnostiikka-, kemianteollisuuden ja terveydenhoitoalan tuotteiden, laitteiden, välineiden, tarvikkeiden ja palvelujen tuotanto ja valmistus, myynti, maahantuonti ja maastavienti, lääkekehitys ja näihin liittyvä liiketoiminta sekä kaikkiin edellä mainittuihin aloihin liittyvä tutkimus- ja tuotekehitystoiminta, ja teknologisten palvelujen myynti, teknologiansiirto ja lisensiointi, suunnittelu ja konsultointi, sekä kaikki muu laillinen liiketoiminta. Yhtiö voi toimintaansa varten hallita, omistaa, antaa vuokralle sekä myydä osakkeita, muita arvopapereita, osuuksia ja kiinteistöjä.
Address
Raisionkaari 55
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 16 | 37 | 51 | 27 | 61 |
| Staff expenses | −0 | — | −10 | −0 | −23 |
| EBITDA | −2 | 13 | 21 | 1 | 16 |
| Depreciation & amort. | −3 | −3 | −3 | −3 | −0 |
| EBIT | −6 | 9 | 17 | −2 | 16 |
| Net financials | −2 | −1 | −1 | −0 | −0 |
| Profit before tax | −7 | 8 | 16 | −3 | 16 |
| Tax | −0 | −0 | 3 | −2 | 3 |
| Net profit | −7 | 8 | 13 | −1 | 13 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 71 | 67 | 76 | 49 | 61 |
| Equity | −6 | 2 | 15 | 15 | 27 |
| Long-term debt | 45 | 20 | 7 | 0 | 0 |
| Short-term debt | 33 | 45 | 53 | 35 | 33 |
| Total debt | 77 | 65 | 61 | 35 | 33 |
EBITDA margin
25.9%
This company
15.8%
Market median
+64% vs market
20212025
Equity ratio
44.8%
This company
38.2%
Market median
+17% vs market
20212025
Return on equity
46.2%
This company
18.4%
Market median
+151% vs market
20212025
Net profit margin
20.5%
This company
8.1%
Market median
+153% vs market
20212025
Asset turnover
1.01×
This company
1.12×
Market median
+10% vs market
20212025
Debt / equity
1.23×
This company
0.62×
Market median
-98% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via PRH / YTJ · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via PRH / YTJ · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via PRH / YTJ · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via PRH / YTJ · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JP Chief Executive Officer | Chief Executive Officer | 2014 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2014 | |
| Chairperson | 2014 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Preclinapps Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jukka Pekka Rissanen | Chief Executive Officer | 0 companies |
| Harri Jari Jukarainen | Board of Directors | 0 companies |
| Saku Tuomas Ruohonen | Chairperson | 0 companies |